PRediction Of Glycemic RESponse Study

Running, not enrolling

Conditions studied: Glycemic Response

In brief

The purpose of PROGRESS is to engage and intensively monitor 1000 individuals' dietary intake, activity levels, and continuous glucose values over 10 days, link to clinical events out to 3-years, and use that data along with genomic, microbiome, electronic health record (EHR), and other biomarker data to develop a predictive model of individual glucose responses to nutrient intake in individuals with and without type 2 diabetes.

Key facts

Study ID

NCT04881019

Run by

Scripps Translational Science Institute

People needed

1070

Starts

2021-06-08

Expected to finish

2025-12-31

Last updated by the study team

2025-05-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 18 years.

You may not qualify if…

• Type 1 diabetes mellitus
• Unable to participate in or comply with any of the testing modules asked during the study
• Currently pregnant
• Prior bariatric surgery
• Chemotherapy or radiation treatment for cancer in the past year
• Inflammatory bowel disease
• Known skin allergy to adhesives and nickel (or other contraindications to continuous glucose monitoring)
• Currently taking any oral steroids(these medications may impact glucose levels)
• Antibiotic use in the last 3 months prior to the start of the study or planned use during the duration of the study
• Non-dietary, supplemental probiotic use either daily or weekly
• Hospice care
• End stage renal disease

Where it is running

• Scripps Research Translational Institute — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.